Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

19 trials with published results (11%)

Research Maturity

67 completed trials (39% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.8%

10 terminated out of 172 trials

Success Rate

87.0%

+0.5% vs benchmark

Late-Stage Pipeline

6%

11 trials in Phase 3/4

Results Transparency

28%

19 of 67 completed with results

Key Signals

19 with results87% success

Data Visualizations

Phase Distribution

127Total
Not Applicable (89)
Early P 1 (1)
P 1 (11)
P 2 (15)
P 3 (7)
P 4 (4)

Trial Status

Completed67
Recruiting45
Unknown28
Not Yet Recruiting13
Terminated10
Withdrawn4

Trial Success Rate

87.0%

Benchmark: 86.5%

Based on 67 completed trials

Clinical Trials (172)

Showing 20 of 20 trials
NCT07185022Not ApplicableRecruiting

Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion

NCT03911388Phase 1Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT06784518Not ApplicableNot Yet RecruitingPrimary

Stroke Cerebral Reorganization Pathways (SPECTRE)

NCT00593203Enrolling By InvitationPrimary

Brain Tissue Specimen Collection

NCT05508789Phase 3Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT05318976Phase 2Completed

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

NCT05578300Recruiting

Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific

NCT04954248Not ApplicableTerminatedPrimary

Pilot Study for PET/MR Imaging of Covid-19

NCT03678194Not ApplicableRecruiting

Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application

NCT07451769Not ApplicableNot Yet Recruiting

Selective Activation of the Adrenomedullin Receptors in Migraine

NCT05522387Phase 2Terminated

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

NCT04973332Not ApplicableCompleted

Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke

NCT04992195Recruiting

Impact of COVID-19 Vaccines on Cerebrovascular Health

NCT03592563Recruiting

CUHK Brain Health Longitudinal Study

NCT05386108Phase 1Recruiting

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

NCT07305948RecruitingPrimary

Evaluation of a New MRI Technique to Reduce Breathing-Related Artifacts in Brain Imaging

NCT07352852Recruiting

Rapamycin-Eluting Vertebral Stents In The Real-World Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

NCT07353736Not Yet Recruiting

Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis

NCT07324330Not ApplicableRecruiting

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

NCT07340788Not ApplicableNot Yet Recruiting

Amylin-Induced Migraine Attacks Without Aura

Scroll to load more

Research Network

Activity Timeline